HOME
Leading the way to a cure

LUPUS NEWS

New Treatment Could Potentially Benefit Irish SLE Patients, Find Researchers

May 8, 2013

Researchers from the Royal College of Surgeons in Ireland (RCSI) have discovered that a new treatment for the inflammatory condition, Systemic Lupus Erythmstosus (SLE) could potentially benefit Irish patients who suffer from the condition.

SLE is an autoimmune disease whereby a person's immune system attacks the body's cells and tissue, resulting in inflammation and tissue damage. SLE most often harms the skin, joints, blood vessels, kidneys and the nervous system. SLE is a rare condition in Ireland, affecting approximately 1,500 people. It can affect up to 10 times as many women as men. The research has identified Irish SLE patients that are susceptible to active disease and increased organ damage brought on by lupus as it progresses. This is due to the presence of high levels of a chemical messenger called B Lymphocyte Stimulator (BLyS) in the body. This messenger can cause the body's cells to produce antibodies that attack its own tissues, thus causing organ damage.

***

Click here to read the full article.

Source: News-Medical.Net


New Treatment Could Potentially Benefit Irish SLE Patients, Find Researchers

May 8, 2013

Researchers from the Royal College of Surgeons in Ireland (RCSI) have discovered that a new treatment for the inflammatory condition, Systemic Lupus Erythmstosus (SLE) could potentially benefit Irish patients who suffer from the condition.

SLE is an autoimmune disease whereby a person's immune system attacks the body's cells and tissue, resulting in inflammation and tissue damage. SLE most often harms the skin, joints, blood vessels, kidneys and the nervous system. SLE is a rare condition in Ireland, affecting approximately 1,500 people. It can affect up to 10 times as many women as men. The research has identified Irish SLE patients that are susceptible to active disease and increased organ damage brought on by lupus as it progresses. This is due to the presence of high levels of a chemical messenger called B Lymphocyte Stimulator (BLyS) in the body. This messenger can cause the body's cells to produce antibodies that attack its own tissues, thus causing organ damage.

***

Click here to read the full article.

Source: News-Medical.Net



1.5 million

people in the U.S. have Lupus.

100 million

dollars committed to lupus research by the Alliance for Lupus Research.


We're walking across the United States to raise awareness and funds for lupus research.

Can't make it? Join our National Virtual Walk to participate anytime, anywhere.


Show your support by visiting the Alliance for Lupus Research online store. Discover the perfect gift, or prepare for a walk with our selection of apparel and accessories.

Powered by Convio
nonprofit software